| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 25,897 | 30,893 | 38,404 | | Cost of Revenue | 17,443 | 19,016 | 29,410 | | | Gross Profit | 8,454 | 11,877 | 8,994 | | | Operating Expenses | | Research Development | 2,750 | 1,267 | 1,243 | | Selling General and Administrative | 11,064 | 8,837 | 9,605 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,360) | 1,773 | (1,854) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 229 | 874 | 3,079 | | Earnings Before Interest And Taxes | (5,131) | 2,647 | 1,225 | | Interest Expense | 6 | 6 | 5 | | Income Before Tax | (5,137) | 2,641 | 1,220 | | Income Tax Expense | (2,002) | 1,033 | 450 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,135) | 1,608 | 770 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (3,135) | 1,608 | 770 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,135) | $1,608 | $770 |
|
1.00% Nasdaq 0.00%
Income Statement
